Volpara Health Technologies (VHT)
Volpara Health Technologies Ltd. is a research, development, and manufacturing company, which engages in providing breast imaging analytics and analysis products that improve clinical decision-making and the early detection of breast cancer. The company was founded by John Michael Brady, Ralph Highnam, Martin Yaffe and Nico Karssemeijer in 2009 and is headquartered in Wellington, New Zealand.
|Market Price at 20-11-2017||$0.70|
|Price to Earnings Ratio||-6.25|
|Market Capitalisation||$101.64 (million)|
|Return on Equity (ROE)||-78.21%|